School of Medicine


Showing 1-7 of 7 Results

  • Ivana Maric

    Ivana Maric

    Assistant Professor (Research) of Pediatrics (Neonatology)

    BioIvana Maric is an Assistant Professor in the Pediatrics Department at the Stanford University School of Medicine. Her research focuses on applying machine learning to improving maternal and neonatal health. Her main focus has been on developing machine learning models for early prediction of adverse outcomes of pregnancy from omics and electronic health records data, that could guide development of low-cost, point of care diagnostic tools. Her main interest is in solutions that are applicable worldwide and especially in low-resource settings. Previously, her research focused on information theory, a mathematical discipline tightly related to statistics and machine learning. She is a recipient of the 2021 Rosenkranz Prize awarded for innovative work to improve health in low- or middle-income countries. She is also a co-recipient of the 2013 IEEE Communications Society Best Tutorial Paper Award.

    She received BS degree from the University of Novi Sad, Serbia, MS and PhD at Rutgers University and postdoctoral training at Stanford University. She served as an Associate Editor for the IEEE Communications Letters from 2009 to 2012 and for the Trans. on Emerging Telecommunications Technologies from 2016 to 2018.

  • Katherine Rachel McCallie

    Katherine Rachel McCallie

    Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine

    Current Research and Scholarly InterestsLeveraging electronic health record (Epic) for improvement in NICU outcomes
    Quality improvement in the NICU
    Nutrition & growth in premature infants

  • Mads Melbye

    Mads Melbye

    Visiting Professor, Pediatrics - Neonatal and Developmental Medicine

    BioMads Melbye, MD, DMSc, is visiting Professor in the Department of Pediatrics at Stanford University School of Medicine. He is also Director of the Danish Cancer Institute (DCI), Research Director at the Danish Cancer Society in Denmark, and Professor in Medical Epidemiology at Copenhagen University in Denmark. From 2016-2020 he was President and CEO at Statens Serum Institut, Copenhagen, Denmark. Previous positions at e.g. the National Cancer Institute, NIH, USA, before he became State Epidemiologist in Denmark, and later Head of Department of Epidemiology Research, and Division Director of Epidemiology and Disease Surveillance, Statens Serum Institut. Previous academic positions as Danish Research Council Professor, NORFA professor, and Foreign Adjunct Professor at Karolinska Institute in Sweden. He has written more than 700 publications (H-index: 108/132 (Web of Science/Google scholar) and is the Dane with most papers in high impact journals in general medicine (NEJM, Lancet, JAMA). He is among the worlds top 2% of scientists as listed in the AD Scientific Index 2023. He is knighted by Her Majesty Queen Margrethe II of Denmark, and has recieved e.g. the Novo Nordisk Prize, the large Erhoff Prize, and the Anders Jahre Prize (young researchers), Oslos, Norway. He is e.g. chairman of the scientific committee at the Danish Health Insurance Fund, member of the scientific advisory board for Oslo University Hospital, member of the A.P. Møller and Chastine Mc-Kinney Møller Foundation (medicine), and board member of the Norwegian Cancer Registry. Has previously served as e.g. chairman of the Governing Council, WHO's International Agency for Research on Cancer in Lyon, France, chairman of the Nordic Medical Research Council’s coordinating body (NOS-M), vice-chairman of the Danish Medical Research Council, chairman of the Ministry of Science, Technology and Innovation's committee on Registry Research (KOR), chairman of the Scientific Council, IARC, Lyon, France, and member of the Novo Nordisk Prize Committee. Together with Professor Stephen Quake he founded Mirvie Inc. in 2018, a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.